
Roukoz Boulos Chamoun MD
Brain & Spinal Tumor, Pituitary Surgery, Skull Base
Professor, Neurosurgery Program director University Kansas School of Medicine
Join to view full profile
4000 Cambridge StKansas City, KS 66160
Phone+1 913-588-1227
Dr. Chamoun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Roukoz Chamoun, MD, is a neurosurgeon based in Kansas City, KS, specializing in brain and spinal tumors, pituitary surgery, and skull base surgery. He completed his medical education at Lebanese University School of Medicine in 2000 and his neurological surgery residency at Baylor College of Medicine from 2007 to 2011. Dr. Chamoun has significant expertise in neurosurgical oncology, skull base surgery, interventional neuroradiology, endovascular neurosurgery, and cerebrovascular disease. He has contributed multiple publications to the field, including research on neuroimaging margins in gliomas and the impact of virtual interviews on neurosurgery residency matches. Dr. Chamoun received the CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation in 2013.
Education & Training
Baylor College of MedicineResidency, Neurological Surgery, 2007 - 2011
Lebanese University School of MedicineClass of 2000
Certifications & Licensure
KS State Medical License 2012 - 2027
MO State Medical License 2012 - 2027
UT State Medical License 2011 - 2014
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
Publications & Presentations
PubMed
- The efficacy and safety of poly ADP-ribose polymerase (PARP) inhibitors in patients with high-grade glioma (HGG): A systematic review and meta-analysis.Farhang Rashidi, Mohammadmahdi Sabahi, Ali Allahdadi, Pouria Delbari, Mohammad Amin Habibi
Journal of Neuroimmunology. 2026-10-01 - Clear neuroimaging margin at the brain-tumor interface is associated with gross total resection and longer survival in non-enhancing diffuse gliomas.Anand A Dharia, Domenico A Gattozzi, Joseph S Domino, Adam G Rouse, Roukoz B Chamoun
Journal of Neurosurgical Sciences. 2025-06-01 - Is SSRI use a risk factor for intracranial hemorrhage after craniotomy for tumor resection?Bradley J Estes, Ahmad R Masri, Roukoz Chamoun
World Neurosurgery. 2024-04-01
Journal Articles
- Three-Dimensional Printed Model Used to Teach Skull Base Anatomy Through a Transsphenoidal Approach for Neurosurgery ResidentsJeremy C Peterson, Paul J Camarata, Roukoz B Chamoun, Kushal J Shah, D David Beahm, Operative Neurosurgery
Authored Content
- Very Large Metastases to the Brain: Retrospective Study on Outcomes of Surgical ManagementMay 2018
- Very Large Metastases to the Brain: Retrospective Study on Outcomes of Surgical ManagementMay 2018
- Laser Ablation After Stereotactic Radiosurgery: A Multicenter Prospective Study in Patients with Metastatic Brain Tumors and Radiation Necrosis RelatedMay 2018
Press Mentions
GT Medical Technologies Announces 2021 GammaTile® Therapy ELITE Member Roster for Use of Its Innovative Brain Tumor TreatmentFebruary 22nd, 2022
Professional Memberships
- Member
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: